Yoplait announces new yogurts for spring
MINNEAPOLIS — Yoplait, a brand from General Mills, on Thursday announced two new spring seasonal yogurts to its lineup. The two flavors, Yoplait Light margarita and Yoplait Original sweet tea-flavored yogurt, are available for a limited time.
"Consumers are continually looking for new and different ways to enjoy the goodness of yogurt," said Blake Holman, associate marketing manager, Yoplait. "The popularity of cocktail-inspired, sweet and refreshing flavored drinks rises when the weather gets warm. So in response to consumer’s desires, Yoplait took favorite flavors to sip and turned them into yogurt that can now be enjoyed any time of the day. Whether it’s a margarita with friends or sweet tea on the porch, consumers love the variety and flavors but without actually consuming the real thing."
The new Yoplait spring seasonal flavors are available nationally in 6-oz., single-serve cup containers; 4-oz. four-packs; and 6-oz., eight-count fridge packs that contain four Yoplait Light margarita and four harvest peach; and four Yoplait Original peach sweet tea and four strawberry. The suggested retail price is $.75 for a 6-oz. single serve, $2.79 for a 4-oz. four-pack and $5.75 for the 6-oz. eight-count fridge packs.
CVS/pharmacy announces donation of drug collection units
WOONSOCKET, R.I. — CVS/pharmacy is teaming up with The Partnership at Drugree.org to create a community donation program through which local police departments can apply to receive a drug collection unit to help their communities safely dispose of unwanted medications, including controlled substances, the pharmacy retailer announced on Thursday.
As part of CVS/pharmacy’s Medication Disposal for Safer Communities program, up to 1,000 receptacles will be awarded to police departments through an application process that will launch on May 1. The Partnership at Drugfree.org will obtain the drug collection units from MedReturn.
"As part of our on-going commitment to combat prescription drug abuse, we have participated in events for many years with law enforcement to help safely dispose of expired, unused or unwanted medication," stated Josh Flum, SVP of retail pharmacy at CVS Caremark. "Through this donation program, CVS/pharmacy and The Partnership at Drugfree.org will now provide our communities with a permanent drug disposal solution at their local police departments."
CVS/pharmacy is the only retail pharmacy sponsor of The Partnership at Drugfree.org’s Medicine Abuse Project, a multi-year initiative to prevent a half-million teenagers from abusing prescription medication by the year 2017.
CVS/pharmacy also is a strong supporter of National Prescription Drug Take Back Day being held April 26. Nearly 200 CVS/pharmacy locations across the United States will host drug take back events managed by local law enforcement agencies.
National Prescription Drug Take Back Day, established by the U.S. Drug Enforcement Administration, aims to provide a safe, convenient and responsible means to dispose of prescription drugs, while educating the general public about the potential for abuse of medications. It is held twice each year, in the spring and fall, at thousands of locations in the United States. Since its inception, more than 3.4 million pounds of unneeded medications have been collected and destroyed.
Reports: Actavis pulls cough syrup after product abuse
NEW YORK — A cough syrup produced by Actavis will no longer be available due to the negative light cast on the product stemming from abuse by musicians like Justin Bieber and Soulja Boy, according to a report from the Huffington Post.
Individuals who abuse the cough syrup will often mix it with soda or candy to make it sweeter. The drink — which is colloquially known as "Sizzurp" — can cause hallucinations and drowsiness, and contains 25 times the recommended amount of promethazine and codeine. Last year, musician Lil Wayne suffered seizures after excessive amounts of codeine were found in his system.
"Given [recent media attention], Actavis has made the bold and unprecedented decision to cease all production and sales of its Promethazine Codeine product," a rep for Actavis was quoted as saying. "This attention has glamorized the unlawful and dangerous use of the product, which is contrary to its approved indication."